FDA 305A.

Trial name or title	Randomized, controlled trial of SCH 56592 oral suspension versus fluconazole suspension in the treatment of oropharyngeal candidiasis (OPC) in HIV positive patients
Methods	Patients receive SCH 56592 oral suspension or fluconazole suspension for 14 days. Patients remain on study for 44 days total and re monitored for safety and efficacy of study treatment.
Participants	Estimated enrolment: 300 Inclusion criteria: 18 yrs or older; HIV positive; Have thrush (OC); agree to sexual abstinence of use effective barrier methods of birth control; Able to take study medication and return to clinic
Interventions
Outcomes
Starting date	August 1998
Contact information
Notes	Study completed. No publications provided. Clincal Trials.gov: NCT00002446